Immunic | VTL - Current Liabilities


Immunic reported $38.36M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
BioMarin Pharmaceutical USD 1.66B 870.84M Jun/2026
Cipla INR 70.14B 7.16B Mar/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.04M 533K Mar/2026
CSL USD 4.61B 207M Dec/2025
Enanta Pharmaceuticals USD 44.73M 3.83M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Immunic USD 38.36M 7.74M Mar/2026
Insmed USD 438.74M 77.74M Jun/2026
Omeros USD 85.5M 2.28M Jun/2025
OraSure Technologies USD 25.12M 18.96M Jun/2026
Quidel USD 993.4M 31M Jun/2026
Ultragenyx Pharmaceutical USD 351M 26M Jun/2026
United Therapeutics USD 607.8M 8.7M Jun/2026